Home > Insider Trading > Filing (0001437749-20-024903)

Filing Details

Accession Number:: 0001437749-20-024903
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-04 19:42:09
Reporting Period:: 2020-12-02

Accepted Time:: 2020-12-04 19:42:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1384101	Veracyte Inc.	VCYT	Services-Medical Laboratories (8071)	205455398

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769333	C Giulia Kennedy	6000 Shoreline Court Suite 300 South San Francisco CA 94080	Chief Scientific & Med Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-12-02	540	$55.08	78,859	No	4	F	Direct
Common Stock	Acquisiton	2020-12-04	5,312	$9.05	84,171	No	4	M	Direct
Common Stock	Acquisiton	2020-12-04	4,406	$5.98	88,577	No	4	M	Direct
Common Stock	Acquisiton	2020-12-04	3,750	$20.21	92,327	No	4	M	Direct
Common Stock	Disposition	2020-12-04	3,642	$55.78	88,685	No	4	S	Direct
Common Stock	Disposition	2020-12-04	4,279	$56.86	84,406	No	4	S	Direct
Common Stock	Disposition	2020-12-04	6,094	$57.55	78,312	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-12-04	5,312	$0.00	5,312	$9.05
Common Stock	Stock Option (right to buy)	Disposition	2020-12-04	4,406	$0.00	4,406	$5.98
Common Stock	Stock Option (right to buy)	Disposition	2020-12-04	3,750	$0.00	3,750	$20.21

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,313	2027-03-02	No	4	M	Direct
22,032	2028-03-01	No	4	M	Direct
33,750	2029-02-27	No	4	M	Direct

Footnotes

The reporting person is reporting the withholding of 292 and 248 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 587 and 500 Restricted Stock Units, respectively granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person.
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.
Represents weighted average sales price. Sale prices for the transactions range from $55.27 to $56.13. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $56.28 to $57.11. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $57.31 to $57.90. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter.
The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter.
The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter.